With median transaction multiples hitting an eight-year high in 2025 and private equity pouring nearly $19 billion into the sector in just the first half of the year, demand is strong in the ASC market. According to VMG Health’s 2026 Healthcare M&A Report, the median total invested capital-to-EBITDA multiple for ASC transactions ticked up to 7.9x in 2025, the highest level in at least eight years. Surgery Partners, one of the largest publicly traded ASC operators, trades at an EV/EBITDA multiple of 12.7x-14x based on December 2025 and 2026 estimates respectively, according to VMG Health’s ASC report.
Read the full article: How Much Are ASCs Actually Worth Right Now? //
Source: https://www.beckersasc.com/asc-transactions-and-valuation-issues/how-much-are-ascs-actually-worth-right-now/